{"id":"arm-a-active-comparator-drug","safety":{"commonSideEffects":[{"rate":"40-50%","effect":"Neutropenia"},{"rate":"30-40%","effect":"Thrombocytopenia"},{"rate":"20-30%","effect":"Anemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BCL-2 is a key protein that regulates cell death. By inhibiting BCL-2, the drug allows cancer cells to undergo apoptosis, or programmed cell death. This mechanism is particularly effective in treating certain types of leukemia.","oneSentence":"This drug works by inhibiting the BCL-2 protein, preventing cancer cell survival.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:02:26.778Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Relapsed or refractory acute myeloid leukemia (AML)"},{"name":"Relapsed or refractory acute lymphoblastic leukemia (ALL)"}]},"trialDetails":[{"nctId":"NCT07309393","phase":"NA","title":"Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function","status":"RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2025-12-31","conditions":"Residual Neuromuscular Block","enrollment":240},{"nctId":"NCT04781387","phase":"PHASE2","title":"Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Crestone, Inc","startDate":"2021-01-05","conditions":"Clostridioides Difficile Infection","enrollment":43},{"nctId":"NCT07244991","phase":"NA","title":"Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics","status":"RECRUITING","sponsor":"Cardenal Herrera University","startDate":"2026-01-04","conditions":"Dental Caries, Streptococcus Mutans, Tooth Demineralization","enrollment":200},{"nctId":"NCT07316166","phase":"PHASE4","title":"Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine","status":"RECRUITING","sponsor":"Rhode Island Hospital","startDate":"2026-01-20","conditions":"Postoperative Pain Management","enrollment":120},{"nctId":"NCT07492069","phase":"NA","title":"Life Skills-Based Intervention on Substance Use Intention in Adolescents in Social Care Institutions","status":"NOT_YET_RECRUITING","sponsor":"Universidad Autonoma de Baja California","startDate":"2026-08-30","conditions":"Institutionalization","enrollment":20},{"nctId":"NCT06793397","phase":"PHASE3","title":"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder","status":"RECRUITING","sponsor":"Cybin IRL Limited","startDate":"2025-12-10","conditions":"Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder","enrollment":330},{"nctId":"NCT07426055","phase":"PHASE2, PHASE3","title":"PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer","status":"RECRUITING","sponsor":"Affidea Nu-med Center of Oncological DIagnostics and Therapy","startDate":"2026-03-19","conditions":"Prostate Cancer (Adenocarcinoma), Prostate Brachytherapy, Stereotactic Body Radiation Therapy (SBRT)","enrollment":1200},{"nctId":"NCT05629585","phase":"PHASE3","title":"A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2022-11-28","conditions":"Breast Cancer","enrollment":1174},{"nctId":"NCT06176352","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2024-03-06","conditions":"Choroidal Neovascularization Secondary to Pathologic Myopia","enrollment":280},{"nctId":"NCT07473752","phase":"PHASE1","title":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects","status":"COMPLETED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2023-07-18","conditions":"Phase 1 First-in-human Study Involving Healthy Subjects","enrollment":26},{"nctId":"NCT03424005","phase":"PHASE1, PHASE2","title":"A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2018-03-30","conditions":"Metastatic Breast Cancer","enrollment":792},{"nctId":"NCT07393672","phase":"PHASE2","title":"Effects of Hemp-Derived Cannabinoids on Menopause Symptoms","status":"RECRUITING","sponsor":"Washington State University","startDate":"2026-02-11","conditions":"Menopause, Perimenopause","enrollment":104},{"nctId":"NCT07223502","phase":"PHASE3","title":"A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease","status":"RECRUITING","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2025-12-01","conditions":"Hypertension (HTN)","enrollment":30},{"nctId":"NCT04108156","phase":"PHASE3","title":"A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2019-09-30","conditions":"Diabetic Macular Edema","enrollment":634},{"nctId":"NCT04102371","phase":"PHASE3","title":"Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-08-25","conditions":"Shock, Septic","enrollment":9041},{"nctId":"NCT07441083","phase":"NA","title":"Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-17","conditions":"Sexual Wellness, Women Health","enrollment":60},{"nctId":"NCT06103864","phase":"PHASE3","title":"A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2023-11-23","conditions":"Breast Cancer","enrollment":625},{"nctId":"NCT07436286","phase":"NA","title":"Intra-Umbilical Vein Oxytocin Injection as an Adjunct to Active Management of the Third Stage of Labour","status":"COMPLETED","sponsor":"Dangana Zakari Adeka","startDate":"2018-02-01","conditions":"Postpartum Hemorrhage (PPH), Postpartum Hemorrhage Third Stage of Labour Retained Placenta","enrollment":416},{"nctId":"NCT06931639","phase":"NA","title":"Suicide Preventive Psychosocial Treatment for Youths","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2025-05-28","conditions":"Suicide Attempt, Suicidal and Self-injurious Behavior, Suicide Attempted","enrollment":282},{"nctId":"NCT07366359","phase":"NA","title":"PGE2 Followed by Oxytocin vs Oxytocin in Term PROM (POXY-PROM)","status":"RECRUITING","sponsor":"National Hospital of Obstetrics and Gynecology","startDate":"2026-02-10","conditions":"Premature Rupture of Fetal Membranes, Labor, Induced, Cervical Ripening","enrollment":450},{"nctId":"NCT03929601","phase":"PHASE2","title":"Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-10-30","conditions":"Type 1 Diabetes Mellitus","enrollment":74},{"nctId":"NCT07377136","phase":"NA","title":"Influence of the Urolithin A on the Population With BMI Higher Than 30 During Restricted Eating.","status":"ENROLLING_BY_INVITATION","sponsor":"Charles University, Czech Republic","startDate":"2025-10-08","conditions":"Obesity & Overweight","enrollment":100},{"nctId":"NCT07412223","phase":"PHASE4","title":"Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery","status":"NOT_YET_RECRUITING","sponsor":"Xiangya Hospital of Central South University","startDate":"2026-02-24","conditions":"Pain, Postoperative, Postoperative Ileus","enrollment":152},{"nctId":"NCT06105632","phase":"PHASE2","title":"A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2024-01-09","conditions":"Advanced or Metastatic Breast Cancer","enrollment":333},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT07154706","phase":"PHASE3","title":"Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)","status":"RECRUITING","sponsor":"Nuvation Bio Inc.","startDate":"2025-08-21","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":180},{"nctId":"NCT07393334","phase":"PHASE2","title":"Effects of NLS-133, a Potential Non-Hormonal \"On-Demand\" Male Contraceptive","status":"RECRUITING","sponsor":"Next Life Sciences","startDate":"2025-12-02","conditions":"Male Contraception, Semen Volume, Sperm Motility","enrollment":10},{"nctId":"NCT07389577","phase":"PHASE3","title":"A Study to Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)","status":"COMPLETED","sponsor":"Jecho Biopharmaceuticals Co., Ltd.","startDate":"2022-03-01","conditions":"Wet Age-related Macular Degeneration","enrollment":443},{"nctId":"NCT07064564","phase":"PHASE1","title":"iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Akyso Therapeutics, LLC","startDate":"2026-04-01","conditions":"Opioid Use Disorder","enrollment":33},{"nctId":"NCT05104866","phase":"PHASE3","title":"A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-10-18","conditions":"Breast Cancer","enrollment":732},{"nctId":"NCT06456983","phase":"NA","title":"Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial","status":"RECRUITING","sponsor":"Central Institute of Mental Health, Mannheim","startDate":"2025-02-14","conditions":"Schizophrenia, Treatment Resistant Schizophrenia","enrollment":140},{"nctId":"NCT06871904","phase":"PHASE1, PHASE2","title":"Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2025-04-07","conditions":"Oral Submucous Fibrosis","enrollment":45},{"nctId":"NCT05776927","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-05-29","conditions":"Asthma","enrollment":304},{"nctId":"NCT07381764","phase":"PHASE2","title":"ROMANCE: \"Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer\"","status":"NOT_YET_RECRUITING","sponsor":"Gruppo Oncologico Italia Meridionale","startDate":"2026-03-30","conditions":"Metastatic Colorectal Cancer (CRC)","enrollment":150},{"nctId":"NCT07372144","phase":"PHASE3","title":"Creatine and Cognitive Health in Patients With Early-stage Breast Cancer During and After Chemotherapy Treatment","status":"NOT_YET_RECRUITING","sponsor":"D'Or Institute for Research and Education","startDate":"2026-08-01","conditions":"Breast Cancer","enrollment":227},{"nctId":"NCT05374512","phase":"PHASE3","title":"A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2022-05-16","conditions":"Breast Cancer","enrollment":644},{"nctId":"NCT06909240","phase":"NA","title":"Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DVT-Cph RCT)","status":"RECRUITING","sponsor":"Hvidovre University Hospital","startDate":"2025-11-15","conditions":"Deep Vein Thrombosis (DVT)","enrollment":152},{"nctId":"NCT03972488","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Advanced Accelerator Applications","startDate":"2020-01-08","conditions":"Gastro-enteropancreatic Neuroendocrine Tumor","enrollment":226},{"nctId":"NCT07347340","phase":"PHASE3","title":"Testing Herbal Pretreatment For IVF Success In Women With Low Ovarian Reserve","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-01-01","conditions":"Diminished Ovarian Reserve (DOR)","enrollment":348},{"nctId":"NCT03875781","phase":"PHASE3","title":"Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-06-05","conditions":"Rectal Cancer, Advanced Cancer","enrollment":540},{"nctId":"NCT06497894","phase":"PHASE4","title":"No More Sleepless Nights in Perimenopause","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2026-01-01","conditions":"Insomnia, Menopause","enrollment":54},{"nctId":"NCT07333300","phase":"NA","title":"Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Dermatitis After Application of Marketed Product Compared With Placebo (Water Application).","status":"NOT_YET_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2026-01-04","conditions":"Atopic Dermatitis (AD)","enrollment":20},{"nctId":"NCT05114096","phase":"PHASE4","title":"Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)","status":"RECRUITING","sponsor":"McMaster University","startDate":"2023-07-20","conditions":"Preterm Birth, Premature Birth, Complication of Prematurity","enrollment":3254},{"nctId":"NCT06422507","phase":"PHASE3","title":"A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2024-05-29","conditions":"Diabetic Macular Edema","enrollment":333},{"nctId":"NCT07310524","phase":"NA","title":"COMPARISON OF OPIOID-FREE AND OPIOID-BASED ANESTHESIA TECHNIQUES ON qNOX INDEX IN ABDOMINAL SURGERY UNDER GENERAL ANESTHESIA","status":"COMPLETED","sponsor":"Muhammad Rahman Efendi Nasution","startDate":"2025-09-08","conditions":"Opioid-free Anesthesia","enrollment":42},{"nctId":"NCT07267260","phase":"PHASE2","title":"Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"King Edward Medical University","startDate":"2025-12-16","conditions":"Cirrhoses, Liver","enrollment":154},{"nctId":"NCT07268820","phase":"PHASE4","title":"Heartburn, Gastroesophageal Reflux Disease","status":"RECRUITING","sponsor":"Incheon St.Mary's Hospital","startDate":"2025-07-07","conditions":"GERD","enrollment":160},{"nctId":"NCT07300202","phase":"PHASE1","title":"CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers]","status":"COMPLETED","sponsor":"Oriplantee Company Limited","startDate":"2025-02-13","conditions":"Evaluate the Safety Profile and Tolerability of Orialpha in Healthy Adult Volunteers, Breast Cancer","enrollment":15},{"nctId":"NCT07294495","phase":"NA","title":"Effect of Henagliflozin on Myocardial Fibrosis in Non-Obstructive HCM: A Randomized, Double-Blind, Placebo-Controlled Trial Using 68Ga/18F-FAPI PET/CMR","status":"NOT_YET_RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2026-01-07","conditions":"HCM - Hypertrophic Cardiomyopathy","enrollment":150},{"nctId":"NCT07242131","phase":"NA","title":"Efficacy of Oral Contraceptive, Progesterone, and Inositol on Menstrual Regulation in PCOS","status":"RECRUITING","sponsor":"Ege University","startDate":"2025-12-01","conditions":"Polycystic Ovary Syndrome (PCOS)","enrollment":150},{"nctId":"NCT07290049","phase":"NA","title":"Postoperative Pain After Pulpotomy in Children Using Calcium Silicate Cements With and Without Laser Therapy","status":"RECRUITING","sponsor":"University of Fujairah","startDate":"2025-04-24","conditions":"Symptomatic Irreversible Pulpitis, Symptomatic Irreversible Pulpitis (SIP)","enrollment":46},{"nctId":"NCT07285148","phase":"PHASE1, PHASE2","title":"A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"Beijing Pearl Biotechnology Limited Liability Company","startDate":"2026-06","conditions":"Non-Small Cell Lung Cancer, EGFR Mutation, Metastatic Lung Cancer","enrollment":253},{"nctId":"NCT07279909","phase":"PHASE3","title":"Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hamdard University","startDate":"2024-03-09","conditions":"Diabetes Type 2, Diabetes Mellitus, Experimental, HbA1c","enrollment":500},{"nctId":"NCT07278999","phase":"NA","title":"Photobiomodulation, Er:YAG Laser, and Clobetasol in the Treatment of Oral Lichen Planus.","status":"RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-12-01","conditions":"Oral Lichen Planus, Erosive Lichen Planus, Mucosal Lesions","enrollment":60},{"nctId":"NCT07272993","phase":"NA","title":"Effect of Golden Rice-Piper Crocatum Cookies on Neuropathy Prevention in Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hasanuddin University","startDate":"2025-10-20","conditions":"Diabetic Neuropathy, Diabetes Mellitus (DM), Functional Food","enrollment":102},{"nctId":"NCT06013761","phase":"NA","title":"IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant Epilepsy","status":"COMPLETED","sponsor":"University Hospital Marburg","startDate":"2023-07-25","conditions":"Epilepsy, Intermittent Fasting","enrollment":22},{"nctId":"NCT07262203","phase":"NA","title":"Effect of Diabetic Foot Exercises on Peripheral Vascular Status in Type 2 Diabetes Mellitus Patients","status":"COMPLETED","sponsor":"Universitas Muhammadiyah Surakarta","startDate":"2024-04-01","conditions":"Peripheral Artery Disease (PAD), Diabetes Mellitus Type 2, Diabetic Foot Circulation Impairment","enrollment":44},{"nctId":"NCT05852873","phase":"PHASE3","title":"PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway","status":"ACTIVE_NOT_RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2023-05-12","conditions":"Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection, COVID-19","enrollment":2000},{"nctId":"NCT06042855","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2023-09-05","conditions":"Covid19","enrollment":3214},{"nctId":"NCT04885530","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-06-08","conditions":"Covid19","enrollment":10956},{"nctId":"NCT04501653","phase":"EARLY_PHASE1","title":"Precision Functional Brain Mapping in Psilocybin","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-06-01","conditions":"Psilocybin","enrollment":11},{"nctId":"NCT05029882","phase":"PHASE1","title":"Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2021-10-13","conditions":"Non-Small Cell Lung Cancer, Advanced Solid Tumors, Gastroesophageal Adenocarcinoma","enrollment":520},{"nctId":"NCT06550297","phase":"NA","title":"Medically Tailored Meals for Cardiovascular Health","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-08-28","conditions":"Diet, Healthy, HbA1c, Blood Pressure","enrollment":160},{"nctId":"NCT05151731","phase":"PHASE2","title":"A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2021-12-31","conditions":"Diabetic Macular Edema","enrollment":394},{"nctId":"NCT06463678","phase":"PHASE2","title":"Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis","status":"NOT_YET_RECRUITING","sponsor":"IVIEW Therapeutics Inc.","startDate":"2026-08-01","conditions":"Fungal Keratitis","enrollment":60},{"nctId":"NCT05887271","phase":"PHASE2, PHASE3","title":"A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction","status":"RECRUITING","sponsor":"University of Leicester","startDate":"2023-12-05","conditions":"Heart Failure With Preserved Ejection Fraction, Heart Failure, Diastolic, Diabetes Mellitus, Type 2","enrollment":63},{"nctId":"NCT07145996","phase":"NA","title":"AI-Enhanced Telerehabilitation Program Using Automated Video Analysis and Personalized Feedback on Pain, Disability, Mobility, Endurance, for Chronic Non-Specific Low Back Pain in College Students.","status":"NOT_YET_RECRUITING","sponsor":"Majmaah University","startDate":"2025-10-01","conditions":"Non Specific Low Back Pain","enrollment":120},{"nctId":"NCT07183592","phase":"NA","title":"Impact of Infusion Line Change Frequency on Infectious Complications Related to Central Venous Catheters in the ICU - A Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Angers","startDate":"2026-01","conditions":"Intensive Care (ICU), Central Venous Catheter Related Infections, Critical Care Nursing","enrollment":2830},{"nctId":"NCT06463665","phase":"PHASE2","title":"Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer","status":"RECRUITING","sponsor":"Genelux Corporation","startDate":"2024-09-26","conditions":"Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-squamous Non Small Cell Lung Cancer","enrollment":142},{"nctId":"NCT07142252","phase":"PHASE2","title":"Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2025-11-13","conditions":"Type 1 Diabetes Mellitus","enrollment":66},{"nctId":"NCT07119645","phase":"NA","title":"NT-II™ Collagen for Joint Discomfort and Function","status":"NOT_YET_RECRUITING","sponsor":"Hofseth Biocare ASA","startDate":"2025-10-19","conditions":"Activity-Related Knee Discomfort, Joint Discomfort, Functional Joint Pain","enrollment":120},{"nctId":"NCT05608005","phase":"PHASE1, PHASE2","title":"Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2022-11-03","conditions":"Influenza, Healthy Volunteers","enrollment":581},{"nctId":"NCT07187284","phase":"PHASE1, PHASE2","title":"EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Zhongda Hospital","startDate":"2025-09-30","conditions":"HCC - Hepatocellular Carcinoma","enrollment":62},{"nctId":"NCT07182292","phase":"NA","title":"Effect of a Combined Exercise and Anti-Inflammatory Nutritional Intervention in Frail Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Fundacion Miguel Servet","startDate":"2025-10-01","conditions":"Frail Elderly Syndrome, Malnutrition Elderly","enrollment":158},{"nctId":"NCT07178379","phase":"NA","title":"Hysteroscopy Anesthesia for Relief of Pain","status":"NOT_YET_RECRUITING","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2025-09-06","conditions":"Pain Management, Outpatient Hysteroscopy, Local Anesthesia","enrollment":70},{"nctId":"NCT06718803","phase":"NA","title":"A Mobile App for Hot Flashes and Sleep Disturbances","status":"COMPLETED","sponsor":"Baylor University","startDate":"2025-01-10","conditions":"Hot Flashes","enrollment":90},{"nctId":"NCT07172139","phase":"NA","title":"Transcranial Magnetic Stimulation and Pharmacologic/Probiotic Interventions for Diarrhea-Predominant IBS","status":"NOT_YET_RECRUITING","sponsor":"Rui Li","startDate":"2025-09","conditions":"IBS (Irritable Bowel Syndrome)","enrollment":140},{"nctId":"NCT04684589","phase":"PHASE2","title":"Effect of PDE5 Inhibition on Adipose Metabolism in Humans","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2021-03-16","conditions":"Obesity","enrollment":89},{"nctId":"NCT07145281","phase":"NA","title":"Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study","status":"COMPLETED","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2022-11-10","conditions":"Gender Dysphoria, Adult, Blood Coagulation, Coagulation Factors","enrollment":30},{"nctId":"NCT06238843","phase":"PHASE3","title":"A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma","status":"RECRUITING","sponsor":"Innovent Biologics (Suzhou) Co. Ltd.","startDate":"2024-06-30","conditions":"Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma","enrollment":450},{"nctId":"NCT05695352","phase":"PHASE2","title":"Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days","status":"RECRUITING","sponsor":"InnovaGyn, Inc.","startDate":"2022-06-28","conditions":"Pregnancy Prevention","enrollment":21},{"nctId":"NCT07123675","phase":"NA","title":"AI-Assisted Blood Pressure Control During Anesthesia","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tsinghua Chang Gung Hospital","startDate":"2025-09-01","conditions":"General Anesthesia","enrollment":40},{"nctId":"NCT06131021","phase":"PHASE3","title":"Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2024-04-25","conditions":"Periodontitis, Periodontal Diseases, Periodontal Pocket","enrollment":150},{"nctId":"NCT07074145","phase":"NA","title":"WEAVE NM: Heart Health and Nutrition for Life","status":"RECRUITING","sponsor":"University of New Mexico","startDate":"2025-02-21","conditions":"Hypertension","enrollment":240},{"nctId":"NCT06067737","phase":"PHASE2","title":"Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-02-08","conditions":"Opioid Use Disorder","enrollment":90},{"nctId":"NCT06889025","phase":"NA","title":"Therapeutic Improvement in People With Schizophrenia Undergoing tACS/CBTp (Transcranial Alternating Current Stimulation Applied Pre-cognitive Behavioral Therapy for Psychosis) Associated to Usual Medication Regimen","status":"NOT_YET_RECRUITING","sponsor":"Felicia Iftene","startDate":"2025-07-24","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":28},{"nctId":"NCT07075562","phase":"NA","title":"TACE Plus Bevacizumab for Hepatocellular Carcinoma With Portal Vein Invasion","status":"COMPLETED","sponsor":"The First Hospital of Hebei Medical University","startDate":"2021-06-01","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":180},{"nctId":"NCT05577585","phase":"NA","title":"Ketamine in OCD: Efficacy and Effects on Stress and Cognition","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2022-10-01","conditions":"Obsessive-Compulsive Disorder, Psychiatric Disorder","enrollment":60},{"nctId":"NCT06601218","phase":"PHASE1","title":"Impact of Daily Oral Cannabis Doses in Patients With Cancer","status":"RECRUITING","sponsor":"Shanna Babalonis, PhD","startDate":"2025-06-17","conditions":"Cancer, Cancers, Pain","enrollment":80},{"nctId":"NCT07017855","phase":"NA","title":"Stereotactic Radiosurgery as Second-line Therapy for Ventricular Tachycardia","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-07-01","conditions":"Ventricular Tachycardia, Monomorphic, Ventricular Tachycardia, Sustained, Ventricular Tachycardia (VT)","enrollment":150},{"nctId":"NCT06420375","phase":"PHASE2","title":"Treatment of UC With Novel Therapeutics","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-05-27","conditions":"Ulcerative Colitis Mild, Ulcerative Colitis","enrollment":20},{"nctId":"NCT06538077","phase":"PHASE4","title":"BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2025-02-01","conditions":"Hepatic Encephalopathy, Decompensated Cirrhosis, Minimal Hepatic Encephalopathy","enrollment":336},{"nctId":"NCT07010926","phase":"PHASE2","title":"A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease","status":"NOT_YET_RECRUITING","sponsor":"L2 Bio, LLC","startDate":"2025-08-15","conditions":"Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)","enrollment":120},{"nctId":"NCT06339203","phase":"NA","title":"Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)","status":"RECRUITING","sponsor":"Loma Linda University","startDate":"2024-06-05","conditions":"Cesarean Section Complications, Cesarean Section; Infection","enrollment":400},{"nctId":"NCT06986811","phase":"PHASE2","title":"CEB-01 in Paediatrics With Locally Resectable Abdominal Tumours","status":"RECRUITING","sponsor":"CEBIOTEX","startDate":"2025-05-06","conditions":"Locally Resectable Paediatric Tumours","enrollment":60},{"nctId":"NCT04854096","phase":"PHASE2","title":"Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis","status":"TERMINATED","sponsor":"NS Pharma, Inc.","startDate":"2023-01-31","conditions":"Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis","enrollment":7},{"nctId":"NCT04415853","phase":"PHASE3","title":"Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer","status":"RECRUITING","sponsor":"Sunshine Lake Pharma Co., Ltd.","startDate":"2021-01-21","conditions":"Esophageal Cancer","enrollment":416},{"nctId":"NCT06964230","phase":"PHASE2, PHASE3","title":"A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects","status":"NOT_YET_RECRUITING","sponsor":"T3D Therapeutics, Inc.","startDate":"2026-10-26","conditions":"Alzheimer's Disease","enrollment":376},{"nctId":"NCT06761339","phase":"NA","title":"Clinical Trial Evaluate the Cough-relieving and Expectorant Effects of the Health Supplement AZKA Nasal and Throat for Children in Outpatient-treated Pharyngitis","status":"COMPLETED","sponsor":"Haiphong University of Medicine and Pharmacy","startDate":"2024-12-23","conditions":"Cough Severity, Cough Frequency, Cough Duration","enrollment":24},{"nctId":"NCT04338321","phase":"PHASE3","title":"A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2020-08-21","conditions":"Depressive Disorder, Major","enrollment":676}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"ARM A: Active Comparator Drug","genericName":"ARM A: Active Comparator Drug","companyName":"Grupo Argentino de Tratamiento de la Leucemia Aguda","companyId":"grupo-argentino-de-tratamiento-de-la-leucemia-aguda","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug works by inhibiting the BCL-2 protein, preventing cancer cell survival. Used for Relapsed or refractory acute myeloid leukemia (AML), Relapsed or refractory acute lymphoblastic leukemia (ALL).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}